1. Home
  2. DCTH vs CRMT Comparison

DCTH vs CRMT Comparison

Compare DCTH & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CRMT
  • Stock Information
  • Founded
  • DCTH 1988
  • CRMT 1981
  • Country
  • DCTH United States
  • CRMT United States
  • Employees
  • DCTH N/A
  • CRMT N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CRMT Other Specialty Stores
  • Sector
  • DCTH Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • DCTH 426.3M
  • CRMT 389.6M
  • IPO Year
  • DCTH N/A
  • CRMT N/A
  • Fundamental
  • Price
  • DCTH $11.86
  • CRMT $60.08
  • Analyst Decision
  • DCTH Strong Buy
  • CRMT Hold
  • Analyst Count
  • DCTH 4
  • CRMT 1
  • Target Price
  • DCTH $24.00
  • CRMT $50.00
  • AVG Volume (30 Days)
  • DCTH 873.0K
  • CRMT 123.0K
  • Earning Date
  • DCTH 08-04-2025
  • CRMT 09-03-2025
  • Dividend Yield
  • DCTH N/A
  • CRMT N/A
  • EPS Growth
  • DCTH N/A
  • CRMT N/A
  • EPS
  • DCTH N/A
  • CRMT 2.33
  • Revenue
  • DCTH $53,850,000.00
  • CRMT $1,390,932,000.00
  • Revenue This Year
  • DCTH $155.42
  • CRMT $1.95
  • Revenue Next Year
  • DCTH $37.93
  • CRMT $10.30
  • P/E Ratio
  • DCTH N/A
  • CRMT $25.51
  • Revenue Growth
  • DCTH 1068.87
  • CRMT 0.14
  • 52 Week Low
  • DCTH $7.17
  • CRMT $36.40
  • 52 Week High
  • DCTH $18.23
  • CRMT $72.26
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • CRMT 59.39
  • Support Level
  • DCTH $12.11
  • CRMT $58.67
  • Resistance Level
  • DCTH $14.15
  • CRMT $62.53
  • Average True Range (ATR)
  • DCTH 0.57
  • CRMT 2.20
  • MACD
  • DCTH -0.16
  • CRMT 0.15
  • Stochastic Oscillator
  • DCTH 9.67
  • CRMT 66.36

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: